The present mouse work extends recent studies from our group that showed that conditional deletion of Smo specifically in adult hepatocytes rapidly disrupts hepatocyte metabolism of cholesterol and is sufficient to cause hepatic cholesterol accumulation, dyslipidemia, and altered bile acid pool size and composition.18 Here, SMO is linked to metabolic syndrome.